LOS ANGELES--(BUSINESS WIRE)--The Gores Group, a global investment firm focused on acquiring controlling interests in mature and growing businesses, today announced that it has completed the ...

Mallinckrodt plc is a global specialty pharmaceutical company Lazard is serving as Mallinckrodt’s financial advisor while UBS is serving as CVC’s financial advisor Based in Luxembourg, CVC has ...

CVC agreed to acquire Therakos for $925m in August The investment was made via CVC’s Fund IX Mallinckrodt is the seller CVC Capital Partners has completed the previously announced acquisition of ...

(RTTNews) - Mallinckrodt plc, a specialty pharmaceutical company, announced Monday its agreement to sell Therakos business to investment firm CVC Capital Partners' Fund IX for $925 million, subject to ...

LOS ANGELES--(BUSINESS WIRE)--The Gores Group, a global investment firm focused on acquiring controlling interests in mature and growing businesses, today announced that it has made a binding offer to ...

Global buyout firm CVC Capital Partners has struck a deal to buy immunotherapy company Therakos from specialty pharmaceutical company Mallinckrodt for $925 million. Mallinckrodt, which last November ...

The Gores Group on Wednesday said it has completed the acquisition of medical device maker Therakos Inc. from Johnson & Johnson’s Ortho-Clinical Diagnostics Inc. Gores Group, the Westwood investment ...

Aug 5 (Reuters) - Drugmaker Mallinckrodt said on Monday it will sell its Therakos business to CVC Capital Partners (CVC.AS), opens new tab for $925 million. Dublin-based Mallinckrodt, which bought the ...